Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Michael Dustin of the Kennedy Institute of Rheumatology comments on new research into boosting the immune system's response to cancer with cholesterol, in Nature

The ability to stimulate our immune system in the fight against cancer or autoimmune diseases is now a reality, but there are still challenges to overcome and further medical advances to pursue.

With 50% of people born after 1960 set to be diagnosed with some form of cancer during their lifetime, developing successful treatments is a key focus of biomedical research.

 

This work may give a new meaning to "good" cholesterol.
- Professor Michael Dustin

New research also published in Nature proposes a way to boost the function of anti-tumour T cells, using a metabolic trick to increase the level of cholesterol in the cells' membranes, bringing new hope to patients worldwide.

T cells determine the specificity of our immune response to foreign substances in the body, like tumour cells. They sense these substances through clusters of T-cell receptor proteins on a cell's surface, which then initiate T cell activation. This activation can be enhanced by a number of factors or substances, namely cholesterol on the cell membrane.

The research team has used a drug to stop cholesterol being converted into cholesterol ester, which led to higher cholesterol levels in the cell membrane of killer T cells, promoting clustering of T-cell receptors that bind to the surface of tumour cells. Higher-membrane cholesterol also led to an increase in the speed at which the T cell and tumour cell form a point of embrace called the immunological synapse, a crucial step in our immune response. Together, these factors promoted the release of molecules that trigger tumour-cell death.

"This work may give a new meaning to "good" cholesterol. The potential to combine this approach with an established immunotherapy like anti-PD-1 is exciting as drug combinations offer advantages for targeting heterogeneous or rapidly mutating disease agents- like cancer and viruses", 

Professor Dustin 's research at the Kennedy focuses on immunological synapse (IS), a term he first coined to describe the embrace between T cells and B cells that is necessary to mount an immune response. His current work aims to improve vaccines and immunotherapy by revealing the composition of particular structures related to immunological synapses, defined as synaptic ectosomes, as well as identify ways to manipulate their formation.

 

Image copyright: Nature.

NATURE | NEWS & VIEWS
Cancer immunotherapy: Killers on sterols

Associated article
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
by Yang et al.

 

The immunological synapse explained

 

Similar stories

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Professor Fiona Powrie recognised in Queen’s Birthday Honours

Professor Fiona Powrie was honoured in the 2022 Queen’s Birthday Honours List, published as Her Majesty celebrates her Platinum Jubilee.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Wellcome Trust Investigator Award for Professor Arnon

Congratulations to Professor Arnon on her successful Wellcome Trust Investigator Award entitled: “Spatiotemporal basis of adaptive immunity in the spleen.”

New research suggests targeting blood vessels could be key to controlling fibrotic disease

By studying blood vessels at single cell resolution, Professor Jagdeep Nanchahal and colleagues found that in Dupuytren’s disease, a fibrotic disorder of the hand, the vasculature is key to orchestrating the development of human fibrosis.

Defining the role of resident memory B cells in the fight against influenza

Researchers at the Kennedy Institute of Rheumatology have used 3D and live-imaging to show how resident memory B cells boost antibodies to fight influenza.